Sunday’s PG course, addressing “Diagnosis
and treatment”, was a joint effort with ESHRE
and chaired by Thomas D’Hooghe, Charles Chapron,
and Stephen Kennedy. The course discussed how
new insights into the pathogenesis of endometriosis,
including genetics, and the ontogenesis of endometriosis
associated pain and new technological advances in proteomics
have resulted in novel approaches to the non-invasive
diagnosis and non-hormonal medical treatment of endometriosis.
On Saturday the topic was “Pathogenesis
and research” chaired by Serdar Bulun, Asgi Fazleabas,
Hugh Taylor, and Robert Taylor. This course offered
a systematic review of the pathogenesis and treatment
of endometriosis, and assessed novel concepts of the
aetiology of endometriosis, and discussed the use of
experimental therapies or off-label medications for
patients not benefiting from current treatment options.
The
ESHRE Guideline for the diagnosis and treatment of endometriosis
was presented; according to the best available evidence,
the annual estimated cost for endometriosis appears
to be higher than the cost for Crohn’s disease.
The relevance to diagnose minimal-mild endometriosis,
and the place of surgical treatment were subjects for
debate. The course benefited from lively interactions
between speakers and audience, was well attended by
about 70 registrants. The organisers were later informed
by the ASRM Board that the course had been rated very
highly by the participants.
|